Jump to ContentJump to Main Navigation
The ESC Textbook of Cardiovascular Medicine$
Users without a subscription are not able to see the full content.

Edited by A. John Camm, Thomas F. Lüscher, Patrick W. Serruys

CME Assessment

Click here for more information and links to available questions.

Access token activation

Click here to activate your access token for this title.

References

All references in the book are available to download for free.

Subscriber Login

Forgotten your password?

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Contents

Tumours of the Heart

Chapter:
Tumours of the Heart
Author(s):

Gaetano Thiene,

Marialuisa Valente,

Massimo Lombardi,

Cristina Basso

DOI:
10.1093/med/9780199566990.003.020

Tumours rarely involve the heart; secondary neoplasms (cardiac metastases from lung carcinoma, lymphoma, breast, hepatic, and kidney cancer) are much more frequent than primary neoplasms (20:1).

Ninety per cent of all primary cardiac tumours are benign. Myxoma, by far the most frequent benign tumour (70%), is typically located in the left atrium, and manifests with intracavitary obstruction, embolism, and constitutional symptoms but may also be silent and discovered incidentally by echocardiography. It is also observed in children. Papillary fibroelastoma is an endocardial papilloma, which although quite small, may become symptomatic through embolic events. Typical tumours of the paediatric age group are fibroma, rhabdomyoma, and teratoma.

Primary malignant neoplasms account for 10% of all primary cardiac tumours and are represented by sarcomas (angiosarcoma, leiomyosarcoma, fibrosarcoma, liposarcoma, rhabdomyosarcoma, undifferentiated pleomorphic sarcoma) and primary lymphomas. They usually infiltrate the cardiac walls, but may also be solely intracavitary, mimicking myxoma. Histology with immunohistochemistry of any cardiac mass is mandatory for diagnosis, therapy, and prognosis. Endomyocardial biopsy may be of help for histological investigation without thoracotomy. Malignancies may be cured with surgery and/or chemotherapy/radiotherapy.

Non-neoplastic masses may consist of thrombi and infections, which again can be identified by a thorough surgical pathology examination.

Cardiac non-invasive imaging through transthoracic and transoesophageal echocardiography easily detects heart masses. Cardiac magnetic resonance and computed tomography are helpful complementary investigations, for refining diagnosis and in the post-surgery follow-up.

Oxford Medicine requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.